Cardiovascular disease usually triggers coronary heart disease, stroke, and ischemic
diseases, thus promoting the development of functional failure. Mesenchymal stem cells …

Introduction: Effective therapy of various neurological disorders is hindered on account of
the failure of various therapeutics crossing blood-brain-barrier (BBB). Nanotheranostics has …

Commercially available strontium isopropoxide represents a suitable catalyst/initiator for the
ring‐opening polymerization (ROP) of lactide (LA), ε− caprolactone, δ− valerolactone, δ …

Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized
arterial scaffolds is limited by dense concentric tunica media layers which impede cells …

Nanotheranostics integrates nanomaterials with theranostics. The word “theranostics” refers
to the simultaneous integration of diagnosis and therapy (Sumner and Gao 2008). By …

A nanomedicina a nanotechnológia humán gyógyászatban történõ felhasználását jelenti,
ami egyre nagyobb teret hódít a tudományos kutatásokban11–13. Ez az új terápiai ágazat …

Triple-negative basal-like (TNBL) tumors comprise 70% of the basal-like tumor subtype and
15% of all breast cancers. They are characterized by the non-expression of estrogen …

Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9
million people died from CVDs in 2016, with~ 840,000 of them in the United States alone …

Rak je eden izmed najpogostejših razlogov smrti sodobnega človeka. Zato so raziskave na
področju izboljšav protirakastih zdravilnih učinkovin in novih metod zdravljenja te bolezni …